• Revance Therapeutics (NASDAQ:RVNC) Earns Hold Rating from Analysts at StockNews.com

    来源: Buzz FX / 28 12月 2024 01:41:14   America/Chicago


    Revance Therapeutics (NASDAQ:RVNC) Earns Hold Rating from Analysts at StockNews.com Written by MarketBeat December 28, 2024 Share Link copied to clipboard. StockNews.com started coverage on shares of Revance Therapeutics ( NASDAQ:RVNC - Get
    Read more...
分享